1. Avoiding medication errors when diluting Bendamustine Accord concentrate

   News item 11 March 2023 Pages: 1 - 1

2. Batch of Artificial Eye Ointment recalled in USA

   News item 11 March 2023 Pages: 2 - 2

3. Cephalosporin-related neurotoxicity

   News item 11 March 2023 Pages: 3 - 3

4. Glasdegib: risk of muscle-related AEs

   News item 11 March 2023 Pages: 4 - 4

5. Health Canada safety brief on opioid use in patients with mental health disorders

   News item 11 March 2023 Pages: 5 - 5

6. Ocular decongestants, new warning statement for age restriction of use as proposed by NZ Medsafe

   Media release 11 March 2023 Pages: 6 - 6

7. Pericarditis after monkeypox vaccination

   News item 11 March 2023 Pages: 7 - 7

8. Pholcodine products recalled in Australia due to risk of anaphylaxis

   News item 11 March 2023 Pages: 8 - 8

9. Zolgensma-related acute liver failure: fatal cases

   News item 11 March 2023 Pages: 9 - 9

10. Antidepressant-related pregnancy complications and neonatal disorders

    Clinical study 11 March 2023 Pages: 10 - 10

11. Anxiety and depression increase risk of reporting COVID-19 vaccine-related AEs

    Clinical study 11 March 2023 Pages: 11 - 11

12. Lenvatinib plus pembrolizumab requires monitoring in patients with aRCC

    Clinical study 11 March 2023 Pages: 12 - 12

13. Other adverse reaction research

    News item 11 March 2023 Pages: 13 - 13

14. Abatacept

    Case report 11 March 2023 Pages: 14 - 14

15. Abemaciclib/palbociclib

    Case report 11 March 2023 Pages: 15 - 15

16. Acetazolamide

    Case report 11 March 2023 Pages: 16 - 16

17. Acetylcysteine/corticosteroids

    Case report 11 March 2023 Pages: 17 - 17

18. Aciclovir

    Case report 11 March 2023 Pages: 18 - 18

19. Aciclovir/immune-globulin/glucocorticoids

    Case report 11 March 2023 Pages: 19 - 19

20. Ad26.COV2-S/AZD-1222/tozinameran

    Case report 11 March 2023 Pages: 20 - 20

21. Adalimumab/azathioprine

    Case report 11 March 2023 Pages: 21 - 21

22. Adalimumab/infliximab

    Case report 11 March 2023 Pages: 22 - 22

23. Adalimumab/methylprednisolone

    Case report 11 March 2023 Pages: 23 - 23

24. Afatinib

    Case report 11 March 2023 Pages: 24 - 24

25. Afatinib/osimertinib

    Case report 11 March 2023 Pages: 25 - 25

26. Alcohol/doxorubicin

    Case report 11 March 2023 Pages: 26 - 26

27. Alcohol/metamfetamine/morphine abuse

    Case report 11 March 2023 Pages: 27 - 27

28. Alemtuzumab

    Case report 11 March 2023 Pages: 28 - 28

29. Allopurinol

    Case report 11 March 2023 Pages: 29 - 29

30. Allopurinol

    Case report 11 March 2023 Pages: 30 - 30

31. Amenamevir/quetiapine interaction

    Case report 11 March 2023 Pages: 31 - 31

32. Amfetamine abuse

    Case report 11 March 2023 Pages: 32 - 32

33. Amiodarone

    Case report 11 March 2023 Pages: 33 - 33

34. Amiodarone

    Case report 11 March 2023 Pages: 34 - 34

35. Amiodarone

    Case report 11 March 2023 Pages: 35 - 35

36. Amiodarone/baclofen/cyclobenzaprine

    Case report 11 March 2023 Pages: 36 - 36

37. Amiodarone/digoxin

    Case report 11 March 2023 Pages: 37 - 37

38. Amiodarone/lidocaine/mexiletine

    Case report 11 March 2023 Pages: 38 - 38

39. Amoxicillin/clavulanic-acid

    Case report 11 March 2023 Pages: 39 - 39

40. Amoxicillin/clavulanic-acid

    Case report 11 March 2023 Pages: 40 - 40

41. Amphotericin-B-liposomal/itraconazole

    Case report 11 March 2023 Pages: 41 - 41

42. Ampicillin/sulbactam/cefazolin

    Case report 11 March 2023 Pages: 42 - 42

43. Ampicillin/sulbactam/fentanyl/haloperidol

    Case report 11 March 2023 Pages: 43 - 43

44. Anagrelide

    Case report 11 March 2023 Pages: 44 - 44

45. Analgesics/opioid-analgesics/sertraline

    Case report 11 March 2023 Pages: 45 - 45

46. Anti-infectives/hydroxychloroquine/tocilizumab

    Case report 11 March 2023 Pages: 46 - 46

47. Anti-inflammatories

    Case report 11 March 2023 Pages: 47 - 47

48. Anti-inflammatories

    Case report 11 March 2023 Pages: 48 - 48

49. Antibacterials

    Case report 11 March 2023 Pages: 49 - 49

50. Antibacterials

    Case report 11 March 2023 Pages: 50 - 50